While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...
Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...
European shares were at a record high on Friday, led by technology and healthcare stocks, even as caution prevailed ahead of the U.S. tariff deadline set by President Donald Trump. The pan-European ...
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
Generally, you can count on drugmakers for a steady revenue performance -- since patients need their medicines, revenue holds ...
Here's the list of options activity happening in today's session: These itemized elaborations have been created using the ...
Investing in healthcare stocks has perhaps never been a better idea. The healthcare sector has grown significantly since the start of 2020, aided in large part by increased medical spending during ...
Healthcare shares sold off after UnitedHealth Group said its medical costs rose last quarter, underscoring fears the issue may still weigh on the sector in 2025. The industry bellwether's earnings wer ...
Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.
For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free ...
Stocks started the week lower, pulled downward by investors' worries about the health of the AI trade. Under the hood of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback